Therapeutically active compounds and their methods of use Grant US-11844758-B2 United States of America 19 Dec 2023
Pyruvate kinase activators for use in therapy Grant US-11793806-B2 United States of America 24 Oct 2023
Therapeutically active compounds and their methods of use Grant US-11667673-B2 United States of America 06 Jun 2023
Pharmaceutical compositions of therapeutically active compounds Grant US-11504361-B2 United States of America 22 Nov 2022
Therapeutically active compounds and their methods of use Grant US-11505538-B1 United States of America 22 Nov 2022
Combination therapy for treating malignancies Grant US-11419859-B2 United States of America 23 Aug 2022
Methods of using pyruvate kinase activators Grant US-11234976-B2 United States of America 01 Feb 2022
Therapeutically active compounds and their methods of use Grant US-11021515-B2 United States of America 01 Jun 2021
Therapeutically active compounds and their methods of use Grant US-10946023-B2 United States of America 16 Mar 2021
Pharmaceutical compositions of therapeutically active compounds Grant US-10799490-B2 United States of America 13 Oct 2020
Therapeutically active compounds and their methods of use Grant US-10717764-B2 United States of America 21 Jul 2020
Methods for diagnosing IDH-mutant cell proliferation disorders Grant US-10711314-B2 United States of America 14 Jul 2020
Therapeutically active compounds and their methods of use Grant US-10689414-B2 United States of America 23 Jun 2020
Combination therapy for treating malignancies Grant US-10653710-B2 United States of America 19 May 2020
Therapeutically active compositions and their methods of use Grant US-10640534-B2 United States of America 05 May 2020
Pyruvate kinase activators for use in therapy Grant US-10632114-B2 United States of America 28 Apr 2020
Methods and compositions for cell-proliferation-related disorders Grant US-10610125-B2 United States of America 07 Apr 2020
Pharmaceutical compositions of therapeutically active compounds Grant US-10449184-B2 United States of America 22 Oct 2019
2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of… Grant US-10376510-B2 United States of America 13 Aug 2019
Therapeutically active compounds and their methods of use Grant US-10294215-B2 United States of America 21 May 2019
Therapeutic compounds and compositions Application US-10202339-B2 United States of America 12 Feb 2019
Therapeutically active compounds and their methods of use Grant US-10172864-B2 United States of America 08 Jan 2019
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants… Application US-10111878-B2 United States of America 30 Oct 2018
Therapeutically active compounds and their methods of use Grant US-10028961-B2 United States of America 24 Jul 2018
Therapeutically active compounds and their methods of use Grant US-10017495-B2 United States of America 10 Jul 2018
Pyruvate kinase activators for use in therapy Grant US-9980961-B2 United States of America 29 May 2018
Method for treating cell proliferation related disorders Application US-9982309-B2 United States of America 29 May 2018
Pharmaceutical compositions of therapeutically active compounds Grant US-9968595-B2 United States of America 15 May 2018
Therapeutically active compositions and their methods of use Grant US-9856279-B2 United States of America 02 Jan 2018
Therapeutically active compositions and their methods of use Grant US-9850277-B2 United States of America 26 Dec 2017
Therapeutically active compounds and their methods of use Grant US-9732062-B2 United States of America 15 Aug 2017
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants… Application US-9724350-B2 United States of America 08 Aug 2017
Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1… Grant US-9662327-B2 United States of America 30 May 2017
Therapeutically active compounds and their methods of use Application US-9656999-B2 United States of America 23 May 2017
Therapeutically active compounds and their methods of use Grant US-9579324-B2 United States of America 28 Feb 2017
Therapeutically active compositions and their methods of use Grant US-9512107-B2 United States of America 06 Dec 2016
Therapeutically active compositions and their methods of use Application US-9474779-B2 United States of America 25 Oct 2016
Methods and compositions for cell-proliferation-related disorders Application US-9434979-B2 United States of America 06 Sep 2016